太古可口可樂總裁:十年內在華投資逾120億人幣
太古可口可樂(蘇州)飲料有限公司日前正式破土動工,該項目總投資20億元人民幣(下同),為太古可口可樂迄今在華最大的一筆戰略性投資。據《21世紀經濟報道》引述太古可口可樂總裁蘇薇透露,預計未來十年,太古可口可樂在中國內地的投資總額將超過120億元,主要投資於新廠房、新產線建設和冷飲設備等。
蘇薇指,目前太古可口可樂在華投資,有三個項目處於建設當中,除投資20億元蘇州太古可口可樂外,鄭州和廣州分別建新廠房,分別投資9億和12.5億元。三家新廠都均在2025年底前落成,未來會有眾多新產品和新包裝在崑山生產。(ta/w) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.